BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15882585)

  • 1. Subversion of T lineage commitment by PU.1 in a clonal cell line system.
    Dionne CJ; Tse KY; Weiss AH; Franco CB; Wiest DL; Anderson MK; Rothenberg EV
    Dev Biol; 2005 Apr; 280(2):448-66. PubMed ID: 15882585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch/Delta signaling constrains reengineering of pro-T cells by PU.1.
    Franco CB; Scripture-Adams DD; Proekt I; Taghon T; Weiss AH; Yui MA; Adams SL; Diamond RA; Rothenberg EV
    Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11993-8. PubMed ID: 16880393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
    Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
    Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. At the crossroads: diverse roles of early thymocyte transcriptional regulators.
    Anderson MK
    Immunol Rev; 2006 Feb; 209():191-211. PubMed ID: 16448544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.
    Houston IB; Huang KJ; Jennings SR; DeKoter RP
    Exp Hematol; 2007 Mar; 35(3):374-384. PubMed ID: 17309818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors.
    Laiosa CV; Stadtfeld M; Xie H; de Andres-Aguayo L; Graf T
    Immunity; 2006 Nov; 25(5):731-44. PubMed ID: 17088084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualizing PU.1 activity during hematopoiesis.
    Back J; Allman D; Chan S; Kastner P
    Exp Hematol; 2005 Apr; 33(4):395-402. PubMed ID: 15781329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell development in PU.1-deficient mice.
    Spain LM; Guerriero A; Kunjibettu S; Scott EW
    J Immunol; 1999 Sep; 163(5):2681-7. PubMed ID: 10453009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of regulatory network elements for T cell development by perturbation analysis with PU.1 and GATA-3.
    Anderson MK; Hernandez-Hoyos G; Dionne CJ; Arias AM; Chen D; Rothenberg EV
    Dev Biol; 2002 Jun; 246(1):103-21. PubMed ID: 12027437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1.
    Rosenbauer F; Owens BM; Yu L; Tumang JR; Steidl U; Kutok JL; Clayton LK; Wagner K; Scheller M; Iwasaki H; Liu C; Hackanson B; Akashi K; Leutz A; Rothstein TL; Plass C; Tenen DG
    Nat Genet; 2006 Jan; 38(1):27-37. PubMed ID: 16311598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
    Bourette RP; Grasset MF; Mouchiroud G
    Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymus exclusivity: all the right conditions for T cells.
    Iwasaki H; Akashi K
    Immunity; 2006 Nov; 25(5):697-700. PubMed ID: 17098201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCL expression at critical points in human hematopoietic lineage commitment.
    Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
    Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PU.1-induced mouse calcium-calmodulin-dependent kinase I-like kinase (CKLiK) on apoptosis of murine erythroleukemia cells.
    Yamada T; Suzuki M; Satoh H; Kihara-Negishi F; Nakano H; Oikawa T
    Exp Cell Res; 2004 Mar; 294(1):39-50. PubMed ID: 14980499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45.
    Anderson KL; Nelson SL; Perkin HB; Smith KA; Klemsz MJ; Torbett BE
    J Biol Chem; 2001 Mar; 276(10):7637-42. PubMed ID: 11114304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired repressor activity and biological functions of PU.1 in MEL cells induced by mutations in the acetylation motifs within the ETS domain.
    Kihara-Negishi F; Suzuki M; Yamada T; Sakurai T; Oikawa T
    Biochem Biophys Res Commun; 2005 Sep; 335(2):477-84. PubMed ID: 16098914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dok-related protein negatively regulates T cell development via its RasGTPase-activating protein and Nck docking sites.
    Gugasyan R; Quilici C; I ST; Grail D; Verhagen AM; Roberts A; Kitamura T; Dunn AR; Lock P
    J Cell Biol; 2002 Jul; 158(1):115-25. PubMed ID: 12093790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent repression of T-cell and natural killer cell genes by PU.1 enforces myeloid and B-cell identity.
    Kamath MB; Houston IB; Janovski AJ; Zhu X; Gowrisankar S; Jegga AG; DeKoter RP
    Leukemia; 2008 Jun; 22(6):1214-25. PubMed ID: 18354487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of PU.1 domains in monocyte-specific gene regulation.
    Nishiyama C; Nishiyama M; Ito T; Masaki S; Masuoka N; Yamane H; Kitamura T; Ogawa H; Okumura K
    FEBS Lett; 2004 Mar; 561(1-3):63-8. PubMed ID: 15013752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PU.1 expression delineates heterogeneity in primary Th2 cells.
    Chang HC; Zhang S; Thieu VT; Slee RB; Bruns HA; Laribee RN; Klemsz MJ; Kaplan MH
    Immunity; 2005 Jun; 22(6):693-703. PubMed ID: 15963784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.